Aural Analytics Launches Large-Scale Pivotal Study for Its Respiratory and Speech Motor Control Prediction Software Tools: Plans to Submit the Study to the FDA Late 2021

Aural Analytics anticipates submitting the results of this multi-site, multi-language, 280 participant, prospective, blinded study to the U.S. Food and Drug Administration (FDA) in late 2021.